-- Former Roche, Glutalor executive will help usher in a new era of innovation, 
growth, and expansion for the newly independent blood glucose monitoring company

LifeScan announced today that it has named diabetes-device veteran Brian Heald 
as its new Head of Product effective immediately. Heald brings more than 25 
years of product development success to LifeScan, a world leader in blood 
glucose monitoring and maker of the iconic OneTouch(R) brand, which has 20 
million patients worldwide. 

Photo - https://mma.prnewswire.com/media/847255/Lifescan_Inc___Brian_Heald.jpg 
Logo - https://mma.prnewswire.com/media/749088/Lifescan_Logo.jpg 

Most recently, Heald was Chief Executive Officer of Glutalor Medical, which 
manufacturers and markets advanced continuous glucose monitoring (CGM) 
technology. He has spent much of his career in senior leadership roles at Roche 
Diabetes Care as SVP Head of Global Research & Development and Board Director, 
SVP Head of Operations & Development for North America.

"We are thrilled to have someone with Brian's accomplishments join us at this 
exciting new time of LifeScan's history," says Val Asbury, President and CEO of 
LifeScan. "As we look to grow and expand in diabetes and chronic disease 
management, Brian knows the diabetes device space as well as anyone and also 
knows how to innovate and challenge the status quo. We are excited for our 
future with Brian as a member of the team."

As Head of Product, Heald will lead all aspects of product development 
including R&D, digital development, regulatory, clinical, and partnerships as 
well as The LifeScan Institute. He will also manage product and service 
development with LifeScan's current and future strategic partners, such as 
Welldoc, creator of the award-winning digital therapeutic BlueStar(R), which 
powers OneTouch Reveal(R) Plus and is the first digital therapeutic approved by 
the FDA for adults with type 2 diabetes. "I am looking forward to working with 
a company that has LifeScan's legacy of patient care and quality products," 
Heald says. "Combine that esteemed history with its future growth opportunities 
and our potential to serve even more people around the world is limitless."

About LifeScan
With a vision to create a world without limits for people with diabetes, 
LifeScan is a world leader in blood glucose monitoring – globally more than 20 
million people depend on OneTouch brand products to help them manage their 
diabetes. For over 35 years, LifeScan has had an unwavering commitment to 
improving the quality of life for people with diabetes by developing products 
defined by simplicity, accuracy, and trust. For more information, visit 
www.LifeScan.com and www.OneTouch.com.

SOURCE: Lifescan, Inc.

CONTACT: Bridget Doherty, +1-(610)-428-0038, BDoherty@Lifescan.com